Navigation Links
Mild Asthma, a Revolutionary Therapy from Italian Research

quo;.

Of course, but what about the patient? “It is still very difficult to get across the concept that mild persistent asthma is a chronic disease, particularly in the early stages, when the person only experiences symptoms from time to time – says Dr. Filippo Tesi, President of Federasma, the Italian Asthma Patients’ Association . The management of asthma is however closely related to the patient’s quality of life. If the disease is not correctly managed, symptoms and attacks occur much more frequently. Some of the reasons why patients fail to stick to therapy include the complex nature and the frequency of the treatment, the administration of a number of drugs several times a day, the fear of side effects, even in the long-term, and a lack of faith in the drugs. One approach that does however allow the disease to be managed more simply, would also appear to be an excellent solution for encouraging patients to stick to the treatment”.

Press Office

Intermedia HYPERLINK "mailto:imediabs@tin.it"imediabs@tin.it


'"/>




Page: 1 2 3

Related medicine technology :

1. Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology
2. Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
3. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
4. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
5. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
6. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
7. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
8. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
9. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
10. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
11. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mild Asthma Revolutionary Therapy from Italian Research
(Date:11/6/2009)..., RESEARCH TRIANGLE PARK, N.C., Nov. 6 /PRNew...any advancing orally-available antiviral therapeut...d updates on the development of the company,s lead...rganization (WHO) and the Global Health Security I...viral agent being developed for the treatment of s...
(Date:11/6/2009)..., DETROIT, Nov. 6 C...: CPD ) has launched ketorolac tromethamine ophth...om the US Food and Drug Administration (FDA) for S...) for generic Acular® opthalmic solution on t...ength of ketorolac is therapeutically equivalent t...
(Date:11/5/2009)..., SAN DIEGO, Nov. 5 Althea T...nt and manufacturing services for biopharmaceutica...rmulation Development to the company,s platform of...ointed Dr. James Matsuura, Director of Formulation...am of formulation and analytical scientists, along...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2iTech Medical Provides Update on MPR Clinical Development Plan 58632 1iTech Medical Provides Update on MPR Clinical Development Plan 58632 2iTech Medical Provides Update on MPR Clinical Development Plan 58632 3iTech Medical Provides Update on MPR Clinical Development Plan 58632 4Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 1Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 2Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 3Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 4Prix Galien USA Honors Innovation in Science and Biotech Industries 5128 1Prix Galien USA Honors Innovation in Science and Biotech Industries 5128 2
...xin Demonstrates Promising Clinical Activity in Pa...t Cancers -, SOUTH SAN FRANCISCO, Calif., Nov. 6 ...esented data from three clinical,trials of the com...S-595),at the Chemotherapy Foundation Symposium he...esented from Phase 1 and Phase 1b/2 studies in pat...
...Study of Its Kind, PASADENA, Calif., Nov. 4 Proa... average of 37.2 percent -- and as much as 50,perc...onducted by Kaiser,Permanente Southern California....he Journal of Bone & Joint Surgery, a peer-reviewe...ve-year study tracked more than,625,000 male and f...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 2Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 3Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 4Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 5Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 2Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 3Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds 4
(Date:11/8/2009)...ov. 7 Today, the House ...r, Dahlkemper, Smith, Ellsworth and Lipinski amend...t" (H.R. 3962). The amendment maintains the curren...n and for benefits packages that include abortion....eive affordability credits and those who do not, c...
(Date:11/8/2009)...ov. 7 USAction this eve...for America Act, which will make health care more ... accountable and increase access to health care fo..., "Teddy Roosevelt, FDR and Harry Truman would ...rney. "Today,s vote ranks among our country,s prou...
(Date:11/8/2009)...ov. 8 The following was...ion Rescue Insurrecta Nex. ,, Mr. Terry and hi...hting to keep child-killing by abortion out of any...es: "This is a great first step to victory -- a to...of fighting ahead of us. Our rejoicing must be tem...
(Date:11/8/2009)... House Passage of Health Care Reform Bill ,, ...prove coverage for all Americans ,, BALTIMORE,...ght the United States House of Representatives pas...ould strengthen Medicare for seniors and end discr...ons of Americans out of affordable health coverage...
(Date:11/7/2009)... Nov. 7 Speaker Nancy...of H.R. 3962, the Affordable Health Care for Ameri...ter tonight. Below are the Speaker,s remarks. ,...istoric moment for our nation and for American fam...ty and political philosophy -- as far back as Tedd...
Breaking Medicine News(10 mins):Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4
... Comes a Year Early to Help Combat Vets, PHILADEL...ames B. Peake today said an expansion by the Depar... which provide readjustment,counseling and outreac...years. Fifteen of those centers are already operat...
...ubstantiates Marketability of Propess(R) --, PLYM...BMP Sunstone,Corporation (Nasdaq: BJGP ) (,BMP Su...opess(R) was recommended by the Obstetrics Group a...he Guidelines for Labor Induction in Late-Stage Pr...
...ounced that, based on input from the AGA Institute...sts, it will not implement Clinical Policy Bulleti...ould have restricted the use of an anesthesia prof...alf of AGA members to express concern that this po...
...na didn,t make it to Vietnam, Thailand, study find...-- Several strains of H5N1 bird flu virus that aff...eighboring Thailand and Vietnam, say University of...alysis may help scientists better understand how t...
...Feb. 27 Rising concerns about potential,skin dama...roducts among,health-conscious American women who ..., whitening products are flying off the shelves as...s represent significant growth opportunities for c...
.... 27 Medication Management Systems,(MMS), a leadi...out the,U.S., today announced the appointment of N...ecutive position of President and Chief Operating ...logies that promote efficacy, safety, and adherenc...
Other Medicine News:Health News:VA Has Added 20 New Vet Centers 2Health News:BMP Sunstone's Propess(R) Recommended as First Line Treatment By the Chinese Medical Association 2Health News:BMP Sunstone's Propess(R) Recommended as First Line Treatment By the Chinese Medical Association 3Health News:AGA Institute applauds delay of Aetna sedation restrictions 2Health News:Some Countries May Have Slowed Bird Flu's Spread 2Health News:Health and Fashion - Dow Corning Predicts the Top Trends Driving Consumers to the Beauty Counters 2Health News:Medication Management Systems Names New President and COO 2
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: